J Korean Soc Plast Reconstr Surg Search

CLOSE


Journal of the Korean Society of Plastic and Reconstructive Surgeons 1999;26(1):79-88.
Published online January 1, 1999.
The Effect of FK-506 and Cyclosporine A on Survival of Skin Allograft in Mice.
Young Ha Jung, Seok Kwun Kim
1Department of Plastic & Reconstructive Surgery, College of Medicine, Dong-A University, Pusan, Korea.
2Dr. Jung's Plastic Aesthetic Surgery Clinic.
Abstract
Cyclosporine A, a fungal metabolite, has been known as a potent immunosuppressant in experimental animals and clinical settings of allotransplantation. It has been responsible for improvements on the success of human kidney, liver, heart, lung, and bone marrow allotransplantation. FK-506, a new antilymphocytic agent, has been reported to be a potent immunosuppressive agent discovered in recent years and now being actively investigated. But there are many questions remaining unanswered about the effective dose and possible side effects of FK-506. So we studied the full thickness skin allotransplantation from BALB/c mouse to C57BL mouse to investigate the survival of allografted skin in a mouse model using the different doses of cyclosporine A and FK-506 and to examine the histological findings at the different period. The results were as follows: 1. The mean survival time (MST) of skin allograft in nontreated control group was 8.6 days. 2. The MST of skin allograft in group 3 treated with cyclosprorine A in 10 mg/kg/day for two weeks was 17.7 days, and that of the group 4 treated with FK-506 in 0.5mg/kg/day for two weeks was 19.7 days. The MST of group 4 was longer than that of group 3 (p>0.05). 3. The MST was increased from 19.7 to 23.1 days as the dose of FK-506 increased from 0.5 mg/kg/day to 1 mg/kg/day (p>0.05). 4. There was no difference in MST between long-term(16 weeks) treatment groups of cyclosporine A and FK-506, and the expire rates of the experimental animals were similarly high in both groups (40%, 50%). 5. The combined treatment of low dose cyclosporine A and FK-506 was more effective method to lengthen the MST and to reduce the expire rate than individual high dose treatment of Cs A or FK-506. 6. The expire rates of experimental animal were higher in long-term treatment groups (36.6%) than in short-term treatment groups(7.5%), and the expire rate of combined treatment groups was lowest (20%) among those of long-term treatment groups. The cause of death was not exactly known, but it could be assumed that the toxicity of drugs may result in death. 7. The histologic findings showed necrosis and mononuclear cell infiltration in rejection period that was consistent with the gross findings, but treated groups maintained normal histological architecture a much longer period than the nontreated group. There was no difference in histologic findings between the cyclosporine A treated groups and FK-506 treated groups. With the above results, it can be concluded that FK-506 and Cs A prolonged the survival of skin allotransplantation in mouse. and the low-dose combined treatment of these two drugs is the most effective method for reducing the rejection. It can be expected that adequate use of these immunosuppressants may be useful for skin allografting in severed burn patients and composite tissue transplantation.
TOOLS
Share :
Facebook Twitter Linked In Google+ Line it
METRICS Graph View
  • 1,041 View
  • 0 Download

The Effect of Melatonin on the Random Flap Survival in the Rat.2008 November;35(6)

The Effect of Sphingosine-1-Phosphate in Survival of Grafted Fat Tissues.2010 November;37(6)

The Effect of Platelet-Rich Plasma(PRP) on the Survival of the Autologous Fat Graft.2007 May;34(3)

The Effect of Alloderm on Prevention of Adhesions following Tenorrhaphy in the Rabbits.2007 November;34(6)

The Effect of Botulinum Toxin-A on the Survival of Random-Pattern Cutaneous Flap in Rat.2008 July;35(4)



ABOUT
ARTICLE & SPECIALITY
Article category

Browse all articles >

Speciality

Browse all articles >

BROWSE ARTICLES
AUTHOR INFORMATION
Editorial Office
101-2003, Lotte Castle President, 109, Mapodaero, Mapo-gu, Seoul 04146, Korea
E-mail: apsedit@gmail.com                

Copyright © 2024 by Korean Society of Plastic and Reconstructive Surgeons.

Developed in M2PI

Close layer
prev next